Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP 4:00:00 PM EDT
Market Cap (Intraday) | 13.25M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $0.17 |
50-Day MA | $0.29 |
200-Day MA | $0.60 |
Tonix Pharmaceuticals Holding Corp Stock, NASDAQ:TNXP
26 Main Street, Suite 101, Chatham, New Jersey 07928
United States of America
Phone: +1.862.799.8599
Number of Employees: 103
Description
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.